Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement

Overview

Journal J Innov Card Rhythm Manag

Date 2020 May 29

PMID 32461815

Authors

Srikanth Vedachalam

Schuyler Cook

Tanner Koppert

Toshimasa Okabe

Raul Weiss

Muhammad R Afzal

Affiliations

Soon will be listed here.

Abstract

The subcutaneous implantable cardioverter-defibrillator (S-ICD) is the latest option among devices clinically available for the prevention of sudden cardiac death, with experience from previous trials and postmarketing studies supporting the feasibility and safety of this kind of system. The extracardiac positioning of the S-ICD obviates the need for transvenous leads, which translates into lower incidence rates of lead-related complications and systemic infections. This review will highlight the results of pertinent studies related to the perioperative management of S-ICDs and review potential approaches to minimizing the risk of complications such as hematoma at the pulse generator location, unsuccessful defibrillation due to suboptimal S-ICD lead and generator positioning, and postoperative pain. An extensive literature search using PubMed was conducted to identify relevant articles.

References

Quast A, Baalman S, Betts T, Boersma L, Bonnemeier H, Boveda S . Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing. Am Heart J. 2019; 214:167-174. DOI: 10.1016/j.ahj.2019.05.002. View

Boersma L, El-Chami M, Bongiorni M, Burke M, Knops R, Aasbo J . Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results. Heart Rhythm. 2019; 16(11):1636-1644. DOI: 10.1016/j.hrthm.2019.04.048. View

Knops R, Olde Nordkamp L, de Groot J, Wilde A . Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2013; 10(8):1240-3. DOI: 10.1016/j.hrthm.2013.05.016. View

Sheldon S, Cunnane R, Lavu M, Parikh V, Atkins D, Reddy Y . Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies. Pacing Clin Electrophysiol. 2018; 41(7):799-806. DOI: 10.1111/pace.13349. View

Afzal M, Ahmed A, Prutkin J, Saba S, Cha Y, Friedman P . Multicenter Experience of Concomitant Use of Left Ventricular Assist Devices and Subcutaneous Implantable Cardioverter-Defibrillators. JACC Clin Electrophysiol. 2018; 4(9):1261-1262. DOI: 10.1016/j.jacep.2018.05.002. View

Essandoh M, Otey A, Abdel-Rasoul M, Stein E, Turner K, Joseph N . Monitored Anesthesia Care for Subcutaneous Cardioverter-Defibrillator Implantation: A Single-Center Experience. J Cardiothorac Vasc Anesth. 2016; 30(5):1228-33. DOI: 10.1053/j.jvca.2016.06.007. View

van Dijk V, Boersma L . The subcutaneous implantable cardioverter defibrillator in 2019 and beyond. Trends Cardiovasc Med. 2019; 30(6):378-384. DOI: 10.1016/j.tcm.2019.09.006. View

Afzal M, Badin A, Weiss R, Augostini R, Hummel J . T-wave oversensing from postural changes: A rare cause of inappropriate shock from a subcutaneous defibrillator. HeartRhythm Case Rep. 2017; 3(8):380-383. PMC: 5558167. DOI: 10.1016/j.hrcr.2017.04.004. View

Burke M, Gold M, Knight B, Barr C, Theuns D, Boersma L . Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. J Am Coll Cardiol. 2015; 65(16):1605-1615. DOI: 10.1016/j.jacc.2015.02.047. View

10.

Pfenniger A, Knight B . Evolution of extravascular implantable defibrillator technologies. Prog Cardiovasc Dis. 2019; 62(3):249-255. DOI: 10.1016/j.pcad.2019.04.003. View

11.

Friedman D, Parzynski C, Heist E, Russo A, Akar J, Freeman J . Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry. Circulation. 2018; 137(23):2463-2477. PMC: 5988932. DOI: 10.1161/CIRCULATIONAHA.117.032167. View

12.

Afzal M, Okabe T, Koppert T, Tyler J, Houmsse M, Augostini R . Implantation of subcutaneous defibrillator is feasible and safe with monitored anesthesia care. Pacing Clin Electrophysiol. 2019; 42(12):1552-1557. DOI: 10.1111/pace.13838. View

13.

Lambiase P, Barr C, Theuns D, Knops R, Neuzil P, Johansen J . Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J. 2014; 35(25):1657-65. PMC: 4076663. DOI: 10.1093/eurheartj/ehu112. View

14.

Peddareddy L, Merchant F, Leon A, Smith P, Patel A, El-Chami M . Effect of defibrillation threshold testing on effectiveness of the subcutaneous implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2018; . DOI: 10.1111/pace.13416. View

15.

Miller M, Palaniswamy C, Dukkipati S, Balulad S, Smietana J, Vigdor A . Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing. J Am Coll Cardiol. 2017; 69(25):3118-3119. DOI: 10.1016/j.jacc.2017.04.037. View

16.

Evenson C, Saour B, Afzal M, Knight B, Okabe T, Weiss R . Increased risk of hematoma with uninterrupted warfarin in patients undergoing implantation of subcutaneous implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2019; 42(8):1111-1114. DOI: 10.1111/pace.13754. View

17.

Afzal M, Evenson C, Badin A, Patel D, Godara H, Essandoh M . Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2017; 14(10):1436-1439. DOI: 10.1016/j.hrthm.2017.06.022. View

18.

Gold M, Weiss R, Theuns D, Smith W, Leon A, Knight B . Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014; 11(8):1352-8. DOI: 10.1016/j.hrthm.2014.04.012. View

19.

Santini M, Cappato R, Andresen D, Brachmann J, Davies D, Cleland J . Current state of knowledge and experts' perspective on the subcutaneous implantable cardioverter-defibrillator. J Interv Card Electrophysiol. 2009; 25(1):83-8. DOI: 10.1007/s10840-008-9360-9. View

20.

Wilkoff B, Fauchier L, Stiles M, Morillo C, Al-Khatib S, Almendral J . 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace. 2015; 18(2):159-83. DOI: 10.1093/europace/euv411. View